ArticleInternational journal of women's health2025
Bleeding Through a Pandemic: Women's Lived Experiences with Heavy Menstrual Bleeding During the COVID-19 Pandemic.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction: Heavy menstrual bleeding (menorrhagia) affects 10 million reproductive-age women. Stress is a mechanism for menstrual disorders, and during the COVID-19 pandemic, women reported worsening premenstrual and menstrual symptoms. We hypothesized that there would be a positive association between COVID stress and menorrhagia and a negative association between menorrhagia and mental health. A third objective was to explore women's lived experiences with menorrhagia during the pandemic, including menstrual pain and impact on socialization, sex life, and product use. Methods: This was a secondary data analyses of a cross-sectional study that recruited adult women between the ages of 18-45 years using Dynata, a survey sampling company that maintains a web panel of survey takers across the United States. Menorrhagia was assessed with the Aberdeen Menorrhagia Severity Scale (AMSS), COVID stress with the COVID-19 Pandemic-related Perceived Stress Scale (PSS-10-C), and mental health with the Mental Health Continuum Scale (MHC-SF). We grouped the participants into mild menorrhagia (AMSS score 0-33)" and moderate/severe menorrhagia (AMSS score 34-100) and compared the outcomes using descriptive statistics, correlations, and linear regression. Results: The survey was conducted in May 2021. Among 1,037 initial responses, 360 naturally cycling women met the study eligibility criteria. Women with heavy bleeding reported more COVID-stress than those without heavy bleeding (p < 0.01) and heavy bleeding intensified with increasing COVID-related stress (adj. β = 0.37, 95% CI: 0.21, 0.53). Adjusting for baseline depression, mental health worsened as heavy bleeding increased (adj. β = -0.1, 95% CI: -0.24, -0.03). Compared to those without heavy bleeding, women with heavy bleeding were more likely to report severe pain and bed confinement, less socialization, a negative impact on sex life, and greater use of menstrual products. Conclusion: COVID-related stress affects menstrual physiology and also complex interactions between life-course, social functioning, financial strain, and psychological stress. Our findings support increased awareness of these interactions in gynecologic care during a global pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.